Cutler Group LP Xenon Pharmaceuticals Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$25.44 - $35.16 $15,264 - $21,095	-600 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$25.09 - $33.13 $160,576 - $212,032	-6,400 Reduced 91.43%	600 $1,000
Q3 2021 Oct 26, 2021	BUY	$14.86 - $19.45 $92,132 - $120,590	6,200 Added 775.0%	7,000 $12,000
Q1 2021 Apr 26, 2021	SELL	$13.65 - $21.31 $2,730 - $4,262	-200 Reduced 20.0%	800 $4,000
Q4 2020 Jan 21, 2021	SELL	$9.49 - $16.04 $949 - $1,604	-100 Reduced 9.09%	1,000 $3,000
Q2 2020 Jul 22, 2020	SELL	$10.21 - $14.9 $2,042 - $2,980	-200 Reduced 15.38%	1,100 $2,000
Q1 2020 May 07, 2020	BUY	$8.08 - $17.57 $2,424 - $5,271	300 Added 30.0%	1,300 $3,000
Q4 2019 Feb 06, 2020	BUY	$8.11 - $14.65 $8,109 - $14,650	1,000 New	1,000 $6,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.